Project
For patients
Work Packages
Consortium
Outputs
News
Press
English

Select Page

Got any questions?

communication@optima-oncology.eu

Privacy Protection
Legal Notice & Disclaimer

OPTIMA is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 101034347. IMI2 receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.

Contact

communication@optima-oncology.eu

Tackling Cancer through Real World Data
and Artificial Intelligence

3

Tackling Cancer through Real World Dataand Artificial Intelligence

Tackling Cancer through Real World Data
and Artificial Intelligence